Valuation: Aspen Pharmacare Holdings Limited

Market Cap 70.27B 4.22B 3.78B 3.5B 3.17B 5.92B 402B 5.99B 41.82B 16.66B 210B 15.82B 15.49B 667B P/E 2027 *
14.7x
P/E 2028 * 13x
Enterprise Value 67.86B 4.07B 3.65B 3.38B 3.06B 5.71B 388B 5.78B 40.38B 16.08B 203B 15.28B 14.96B 644B EV / Sales 2027 *
1.83x
EV / Sales 2028 * 1.65x
Free-Float
58.39%
Yield 2027 *
1.54%
Yield 2028 * 1.71%
1 day+0.79%
1 week+1.10%
Current month+1.35%
1 month+2.20%
3 months+7.70%
6 months+15.21%
Current year+37.40%
1 week 154.5
Extreme 154.5
161.98
1 month 152.19
Extreme 152.19
162.5
Current year 104.38
Extreme 104.38
166.21
1 year 90.7
Extreme 90.7
166.21
3 years 90.7
Extreme 90.7
252.96
5 years 90.7
Extreme 90.7
252.96
10 years 64.07
Extreme 64.07
327.5
Manager TitleAgeSince
Chief Executive Officer 62 01/01/1997
Director of Finance/CFO 61 01/01/2009
Chief Operating Officer 63 01/01/1999
Director TitleAgeSince
Director/Board Member 62 01/01/1999
Director/Board Member 65 01/01/1999
Chairman 58 07/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
9/27/23 A Free

Chief Operating Officer

12,236 0.0027%
9/27/23 A Free

Executive/Senior Manager

11,728 0.0026%
9/27/23 A Free

Founder

10,558 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%+1.10%+59.59%-3.92% 4.27B
+0.50%+1.38%+57.09%+129.96% 1,143B
+0.86%+5.14%+45.00%+86.15% 647B
-0.14%+0.42%+25.69%+105.85% 506B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 350B
+0.34%+1.84%+30.70%+54.27% 293B
-0.45%+1.16%+1.74%+26.08% 265B
+0.87%+3.08%+54.69%+72.74% 242B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.22%+0.70%+42.42%+68.37% 403.18B
Weighted average by Cap. +0.25%+0.54%+44.44%+88.92%

Financials

2027 *2028 *
Net sales 37.04B 2.22B 1.99B 1.84B 1.67B 3.12B 212B 3.16B 22.04B 8.78B 111B 8.34B 8.16B 352B 39.4B 2.36B 2.12B 1.96B 1.78B 3.32B 225B 3.36B 23.45B 9.34B 118B 8.87B 8.68B 374B
Net income 4.77B 286M 257M 237M 215M 402M 27.25B 406M 2.84B 1.13B 14.26B 1.07B 1.05B 45.27B 5.24B 314M 282M 261M 236M 441M 29.95B 447M 3.12B 1.24B 15.67B 1.18B 1.15B 49.75B
Net Debt -2.41B -145M -130M -120M -109M -203M -13.79B -206M -1.44B -572M -7.22B -543M -532M -22.91B -5.31B -319M -286M -264M -239M -447M -30.36B -453M -3.16B -1.26B -15.89B -1.2B -1.17B -50.44B
Projected Income Statement - Annual - Aspen Pharmacare Holdings Limited
Logo Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (68.4%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (31.6%): infant nutrition products and consumer products. At the end of June 2024, the group had 24 production sites worldwide.
Employees
7,454
Date Price Change Volume
27/10/26 ZAR 160.47 +0.79% 978,568
26/10/26 ZAR 159.21 +2.10% 970,596
23/10/26 ZAR 155.94 -1.73% 540,507
22/10/26 ZAR 158.68 +0.38% 823,387
21/10/26 ZAR 158.08 -0.41% 718,991
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Aspen Pharmacare Holdings Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
160.47ZAR
Average target price
172.67ZAR
Spread / Average Target
+7.60%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Aspen Pharmacare Holdings Limited